Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review

被引：0
|
作者：
Michael M. Ward
Nima Madanchi
Ali Yazdanyar
Nehal R. Shah
Florina Constantinescu
机构：
[1] National Institute of Arthritis and Musculoskeletal and Skin Diseases,Intramural Research Program
[2] National Institutes of Health,Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine
[3] Virginia Commonwealth University,Current address: Division of Rheumatology
[4] Johns Hopkins University School of Medicine,Department of Emergency and Hospital Medicine
[5] Lehigh Valley Hospital-Cedar Crest,Morsani College of Medicine
[6] University of South Florida,Current address: Division of Hospital Medicine
[7] University of Pennsylvania Perelman School of Medicine,Division of Rheumatology
[8] MedStar Washington Hospital Center,undefined
来源：
Arthritis Research & Therapy | / 25卷
关键词：
Rheumatoid arthritis; Tumor necrosis factor inhibitor; Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review
    Ward, Michael M.
    Madanchi, Nima
    Yazdanyar, Ali
    Shah, Nehal R.
    Constantinescu, Florina
    [J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [2] Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis
    Agarwal, Sandeep K.
    Glass, Roberta J.
    Shadick, Nancy A.
    Coblyn, Jonathan S.
    Anderson, Ronald J.
    Maher, Nancy E.
    Weinblatt, Michael E.
    Solomon, Daniel H.
    [J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (09) : 1737 - 1744
  • [3] Discontinuation Of Tumor Necrosis Factor Inhibitors In Rheumatoid Arthritis Patients In Low Disease Activity: Persistent Benefits.
    Kavanaugh, Arthur
    Lee, Susan J.
    Solomon, Daniel H.
    Greenberg, Jeffrey D.
    Kremer, Joel M.
    Soto, Lilian
    Etzel, Carol J.
    Reed, George W.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S603 - S603
  • [4] Systematic Review of Tumor Necrosis Factor Inhibitor Discontinuation Studies in Rheumatoid Arthritis
    Navarro-Millan, Iris
    Sattui, Sebastian E.
    Curtis, Jeffrey R.
    [J]. CLINICAL THERAPEUTICS, 2013, 35 (11) : 1850 - 1861
  • [5] RISK OF RELAPSE AFTER DISCONTINUING TUMOR NECROSIS FACTOR INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW DISEASE ACTIVITY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Filippi, N.
    Morel, J.
    Combe, B.
    Lukas, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 476 - 476
  • [6] Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity
    Moghadam, Marjan Ghiti
    Vonkeman, Harald E.
    ten Klooster, Peter M.
    Tekstra, Janneke
    van Schaardenburg, Dirkjan
    Starmans-Kool, Mirian
    Brouwer, Elisabeth
    Bos, Reinhard
    Lems, Willem F.
    Colin, Edgar M.
    Allaart, Cornelia F.
    Meek, Inger L.
    Landewe, Robert
    Moens, Hein J. Bernelot
    van Riel, Piet L. C. M.
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68 (08) : 1810 - 1817
  • [7] Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review
    Schlager, Lukas
    Loiskandl, Michaela
    Aletaha, Daniel
    Radner, Helga
    [J]. RHEUMATOLOGY, 2020, 59 (02) : 324 - 334
  • [8] Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients
    Hamann, Philip D. H.
    Pauling, John D.
    McHugh, Neil
    Shaddick, Gavin
    Hyrich, Kimme
    Maiden, Nicola
    Price, Tom
    Hopkinson, Neil
    O'Reilly, Sheila
    Hordon, Lesley
    Griffiths, Ian
    Porter, Duncan
    Capell, Hilary
    Hassell, Andy
    Benitha, Romela
    Choy, Ernest
    Walsh, David
    Emery, Paul
    Knight, Susan
    Bruce, Ian
    Taggart, Allister
    Scott, David
    Harrison, Bev
    Thompson, Paul
    McCrae, Fiona
    Goodfellow, Rhian
    Bukhari, Marwan
    Klimiuk, Peter
    Kitas, George
    Jubb, Ronald
    Abernethy, Rikki
    Clarke, Shane
    Green, Sandra
    Sanders, Paul
    Coulson, Amanda
    [J]. RHEUMATOLOGY, 2019, 58 (12) : 2162 - 2169
  • [9] Predictors of Treatment Initiation with Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis
    Desai, Rishi J.
    Rao, Jaya K.
    Hansen, Richard A.
    Fang, Gang
    Maciejewski, Matthew L.
    Farley, Joel F.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2014, 20 (11): : 1110 - 1120
  • [10] Low rates of adherence for tumor necrosis factor-α inhibitors in Crohn's disease and rheumatoid arthritis: Results of a systematic review
    Herma H Fidder
    Maartje MJ Singendonk
    Mike van der Have
    Bas Oldenburg
    Martijn GH van Oijen
    [J]. World Journal of Gastroenterology, 2013, (27) : 4344 - 4350
12345